Clozapine – Updated labeling and elimination of REMS
June 13, 2025 - The FDA approved updating labeling for clozapine products (Clozaril®, Versacloz®) and officially eliminated the Clozapine Risk Evaluation and Mitigation Strategies (REMS) program for these products.
Download PDF
